Greenwich LifeSciences

Greenwich Reports 80% Recurrence Reduction in FLAMINGO-01

STAFFORD, Texas — December 15, 2025 — Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, announced a preliminary analysis from...

By cGxPwire Editor
December 15, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Greenwich LifeSciences

Greenwich Reports 80% Recurrence Reduction in FLAMINGO-01